| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |